Literature DB >> 18348412

Evaluation of two anti-hepatitis E virus IgM kits.

Sheng-Xiang Ge1, Ying-Jie Zheng, Qing-Shun Guo, Jun Zhang, Qing-Wu Jiang, Mun-Hon Ng, Ning-Shao Xia.   

Abstract

OBJECTIVE: To evaluate two commercial anti-hepatitis E virus (HEV) IgM kits used for differential diagnosis of acute enteric viral hepatitis.
METHODS: The kit for IgM capture assay, was produced with a recombinant HEV structural protein protecting primates against experimental infection by different HEV genotypes, while the other kit for indirect ELISA was produced with recombinant structural proteins from different HEV genotypes. The serum specimens were taken from 241 cases with a confirmed or presumptive diagnosis of hepatitis A and 74 cases with a confirmed or presumptive diagnosis of hepatitis E.
RESULTS: The sensitivity and specificity of the IgM capture assay kit were 97% and 100%, respectively, and the corresponding values for the other kit were 70% and 78%, respectively.
CONCLUSION: The IgM capture assay kit has higher sensitivity and specificity in diagnosing acute enteric viral hepatitis E.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18348412

Source DB:  PubMed          Journal:  Biomed Environ Sci        ISSN: 0895-3988            Impact factor:   3.118


  2 in total

1.  Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the United States.

Authors:  P K Sue; N Pisanic; C D Heaney; T Mixson-Hayden; S Kamili; K Nelson; K B Schwarz; M Forman; A Valsamakis; J Ticehurst; W Karnsakul
Journal:  Transpl Infect Dis       Date:  2015-04       Impact factor: 2.228

2.  Hepatitis E Virus Infection Among Solid Organ Transplant Recipients at a North American Transplant Center.

Authors:  Paul K Sue; Nora Pisanic; Christopher D Heaney; Michael Forman; Alexandra Valsamakis; Annette M Jackson; John R Ticehurst; Robert A Montgomery; Kathleen B Schwarz; Kenrad E Nelson; Wikrom Karnsakul
Journal:  Open Forum Infect Dis       Date:  2016-01-18       Impact factor: 3.835

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.